Dr Reddy’s Calls for a Recall of $5,030 USD of Zenatane Tablets from US market

Healthcare, healthcare investing, investing in healthcare, healthcare investments, investing in healthcare mutual funds, investor healthcare, healthcare stocks to invest in, invest in healthcare, healthcare investor, healthcare investment, healthcare stocks today, healthcare investors, healthcare investment bank, healthcare mutual funds, healthcare savings, medicine stocks, healthcare industry companies, medical stocks, healthcare stock, health sector stocks, healthcare stock market, health services stocks,, investing in pharmaceutical companies, pharmaceutical investment, investing in pharmaceutical stocks, pharmaceutical companies to invest in, best pharmaceutical companies to invest in, pharmaceutical companies stocks, up and coming pharmaceutical companies, drug company stocks, pharmaceutical companies to invest in 2017, pharmaceutical stock, pharmaceutical stocks, pharmaceutical mutual funds, pharmaceutical penny stocks, pharma stocks, pharmaceutical companies, top pharmaceutical stocks, pharmaceutical stocks list, pharmaceutical stocks to watch, best drug company stocks, drug stocks, new pharmaceutical stocks, pharma sector analysis,

Are you thinking about investing in pharmaceutical companies? If so, let’s take a look at what’s been happening in this sector of the market as of late.

Dr Reddy’s Laboratories (NYSE:$RDY), an Indian multinational pharmaceutical company, is recalling roughly 3.25 lakh ($5,030.00 USD) cartons of Zenatane tablets from the United States market due to failed dissolution requirements. These capsules were used for the treatment of extreme recalcitrant nodular acne.

Enter Your E-mail Address To Subscribe

* indicates required
 

This drug is produced by Cipla (NSE:$CIPLA), another Indian  pharmaceutical company, at its Pune facility who then passes it on to Dr Reddy’s.

According to the latest Enforcement Report of the United States FDA, Dr Reddy’s is removing 89,118 lakh ($1379.29 USD) cartons in 20 mg strength and 223,650 lakh ($3461.41 USD) cartons in 30 mg, while 13,221 cartons of the Zenatane tablets in 10 mg strength will be recalled by Dr Reddy’s. The report added that the drug in all three strengths are being recalled because of “Failed Dissolution Specifications: out of specification results observed for low dissolution.”

The United States FDA has said that the current voluntary class 2 recall is national in both the United States and Puerto Rico.

As reported by the FDA, a class 2 recall is put into action in a “situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

Featured Image: twitter